Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(75.0%)
N/A
1(25.0%)
4Total
Phase 2(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04783714Not ApplicableCompleted

Investigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults

Role: lead

NCT03482063Phase 2Completed

The Effects of 12 Weeks Supplementation With a B-vitamin and Herbal Supplement on Neurocognitive Function and Mood

Role: lead

NCT03042273Phase 2Completed

High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection

Role: lead

NCT03483090Phase 2Completed

Investigating the Effect of Deep Sea Krill Oil Supplementation in Osteoarthritis of the Knee

Role: lead

All 4 trials loaded